Changgeng Zhao serves as the Director at Allergan, where he plays a pivotal role in advancing the company's commitment to Real-World Evidence (RWE) initiatives. With a strong foundation in outcomes research and biostatistics, Changgeng leads the development of the Center of Excellence for RWE, focusing...
Changgeng Zhao serves as the Director at Allergan, where he plays a pivotal role in advancing the company's commitment to Real-World Evidence (RWE) initiatives. With a strong foundation in outcomes research and biostatistics, Changgeng leads the development of the Center of Excellence for RWE, focusing on harnessing observational patient-level data from both the US and international markets. His expertise in market research and predictive modeling enables him to design and implement comprehensive studies that yield actionable insights into patient outcomes, particularly in the oncology space.
One of Changgeng's key achievements includes the successful design and establishment of an in-house patient-level data center, which has significantly enhanced Allergan's capabilities in data analytics and statistical modeling. This center serves as a critical resource for conducting rigorous market evaluations and outcome research studies, allowing for the integration of big data analytics into the decision-making process. Changgeng is adept at presenting complex data-driven analyses to diverse audiences, translating intricate methodologies and results into clear, impactful narratives that inform strategic initiatives.
His proficiency in SAS programming and clinical trials further strengthens his ability to lead cross-functional teams in generating evidence that supports product development and market access strategies. As a thought leader in the field, Changgeng Zhao is not only committed to driving innovation at Allergan but also to fostering a culture of data-driven decision-making that ultimately enhances patient care and outcomes.
